Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neuroendocrinology is Scopus-indexed (Q2, CiteScore 6.1), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 0028-3835Verify ISSN ↗1423-0194Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 80 / 250 | 68th | Q2 |
| Endocrine and Autonomic Systems | 8 / 23 | 67th | Q2 |
| Endocrinology | 51 / 132 | 61st | Q2 |
| Cellular and Molecular Neuroscience | 44 / 102 | 57th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1967–present (also 1965), best quartile Q2, CiteScore 6.1.
Neuroendocrinology is Q2 in Endocrinology, Diabetes and Metabolism (rank 80 of 250), Q2 in Endocrine and Autonomic Systems (rank 8 of 23) and Q2 in Endocrinology (rank 51 of 132), by CiteScore 2025. It is ranked in 4 subject areas in all.
Neuroendocrinology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.1, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.949, quartile Q2, with an H-index of 119.
Neuroendocrinology is published by S. Karger AG. Its print ISSN is 0028-3835 and its online ISSN is 1423-0194.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Neuroendocrinology has an h-index of 170 and a 2-year mean of 2.08 citations per paper (OpenAlex). Its Scopus CiteScore is 6.1, quartile Q2. On 2-year citations it ranks #131 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Neuroendocrinology published 72 papers in 2025; its busiest recent year was 2019 with 145. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from China (32.6%), United States (10.3%) and Italy (7.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.